Detection of unknown primary cancer with fluor-deoxy-glucose positron emission tomography

Annals of Otology, Rhinology and Laryngology

Volumn 108, Issue 6, 1999, Pages 623-626

  Jungehülsing, Markus ^a,c   Scheidhauer, Klemens ^a   Eckel, Hans ^a   Pietrzyk, Uwe ^b   Schicha, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; FLUORINE 18;

ADULT; ARTICLE; CANCER DIAGNOSIS; CARCINOMA; CASE REPORT; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOSCOPY; ERYTHROCYTE SEDIMENTATION RATE; ESOPHAGUS; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX; LARYNX; NASOPHARYNX; NEEDLE BIOPSY; OROPHARYNX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKULL BASE; THORAX;

EID: 0344654758     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949910800617     Document Type: Article

References (21)

1. Leonard RJ, Nystrom JS. Diagnostic evaluation of patients with carcinoma of unknown primary tumor site. Semin Oncol 1993;20:244-50.
2. Haskell CM, Cochran AJ, Barsky SH. Metastasis of unknown origin. Curr Probl Cancer 1988;12:5-57.
3. Nissenblatt MR. The CUP syndrome (carcinoma of unknown primary). Cancer Treat Rev 1981;8:211-24.
4. Altmann E, Cadmann E. An analysis of 1539 patients with cancer of unknown primary site. Cancer 1986;57:120-4.
5. Smith PE, Krementz ET, Chapman W. Metastatic cancer without a detectable site. Am J Surg 1967;113:633-7.
6. Steckel RJ, Kagan AR. Diagnostic persistence in working up metastatic cancer with an unknown primary site. Radiology 1980;134:367-9.
7. Coker DD, Casterline PF, Chambers RG. Metastases to the lymph nodes of the head and neck from an unknown primary site. Am J Surg 1977;134:517-22.
8. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992; 102:281-8.
9. Jungehuelsing M, Scheidhauer K. FDG-PET im Vergleich mit CT, MRT, und Sonographie zum Staging von Kopf-, Hals-Plattenepithelkarzinomen. Eur Arch Otorhinolaryngol 1994;II:171-2.
10. Dohnert G. Lymphoepithelioma Schmincke-Regaud. Virchows Arch Pathol Anat Physiol Klin Med 1971;352:279-84.
11. Medina JE. A rational classification of neck dissections. Otolaryngol Head Neck Surg 1989;100:169-76.
12. Abbruzzese JL. An effective strategy for the evaluation of unknown primary tumors. Cancer Bull 1989;41:157-61.
13. Lefebvre JL, Coche-Dequeant B, Ton Van J, Buisset E, Adenis A. Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg 1990;160:443-6.
14. Mancuso A, Harnsberger H, Muraki A. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in head and neck cancer. Radiology 1983;148:709-23.
15. van den Brekel M, Castelijns J, Stel H. Detection and characterization of metastatic cervical adenopathy by MR imaging. Comparison of different MR techniques. J Comput Assist Tomogr 1990;14:581-9.
16. Daugaard G. Unknown primary tumours. Cancer Treat Rev 1994;20:119-47.
17. Hainsworth JD, Greco AF. Managing carcinomas of unknown primary site. Oncology (Huntingt) 1988;2:43-9.
18. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995;13:2094-103.
19. Wilson CBJH. PET scanning in oncology. Eur J Cancer 1992;28:508-10.
20. Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med 1991;32:699-706.
21. Schipper JH, Schrader M, Arweiler D, Müller S, Sciuk J. Positron emission tomography to locate primary tumor in patients with cervical lymph node metastases from an occult tumor. HNO 1996;44:254-7.